NewsRadar
Home
Research
Products & Services
Weekly Newsletter
Online News
News Headlines
Press Release Centre
News Archive
Events

Delta invests €2.5 million in Zapa and €2.9 million in SpineGuard

3 July 2009 21:40
By Tornado Staff

Irish start-up company Zapa Technology has raised an investment of €2.5 million from Delta Partners. Zapa will soon launch its so-called ZapaTag, which promises to be a new customer loyalty technology that uses Near Field Communications (NFC) over mobiles.

Zapa claims to be the first in Europe to deploy NFC technology in a scaled environment. NFC is a technology that should be deployed on all new mobile handsets over the coming years. It should take about three years for all mobile handsets to be NFC compliant. Zapa hopes to bridge this deployment gap by introducing the ZapaTag and deploying contactless readers at the point of sale.

The ZapaTag is technology for customer loyalty schemes. When fixed to the mobile phone, the ZapaTag allows customers to tap at the retailer’s cash register and receive loyalty bonuses and rewards. However, Zapa could target additional applications for its technology. These include the ability to redeem loyalty rewards from advertising posters to payment facilities. The product also provides the retailer with market intelligence in terms of customer profile.

The investment from Delta will support the company in establishing its market position in Ireland, by rolling-out applications from customer loyalty schemes to NFC payments. It intends to showcase its country as a center of excellence for the scaled deployment and execution of NFC services, reaching out to the wider markets of Europe.

Yesterday, French medical device company SpineGuard announced that Delta Partners invested €2.9 million in its first round of funding. Delta’s investment completes the round totaling €11.3 million. The round was first announced early April when Crédit Agricole Private Equity (lead), Innoven Partenaires (co-lead), and A Plus Finance committed €8.4 million. Co-founded this year by former executives at Medtronic Sofamor-Danek and SpineVision, SpineGuard’s objective is to establish its FDA-cleared and CE Marked PediGuard device as the standard of care for safer pedicle screw placement in spine surgery.



Related stories
A Top VC’s Silicon Valley Update - Matthew Howard, NVP
Partech Ventures raises €160 million for venture and seed funds
CCI raises funds for its energy storage systems
Chris Barchak appointed as Partner with Conor
Partech appoints Romain Lavault as general partner


Up


Copyright © 1999-2014
Emerging Technology Research Europe Inc. All rights reserved. Legal Information.